The latest immunotherapy news and developments
Tumour mutational burden (TMB) was an accurate predictor of response to treatment with immune checkpoint…
Many patients with cancer receive immune checkpoint inhibitors that strengthen their immune response against tumour…
In a new study led by Yale Cancer Center, USA, researchers have advanced a tumour-targeting…
Immune checkpoint inhibitors, which boost the immune system’s response against tumour cells, have transformed treatment…
Lower levels of cancer aneuploidy were associated with more favourable outcomes after immune checkpoint inhibition…
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
For patients with some hard-to-treat blood cancers, a new “off-the-shelf” immunotherapy is achieving promising results.…
Immunotherapy together with an experimental cancer drug could offer a new way of treating some…
New research from UVA Cancer Center, USA, could rescue once-promising immunotherapies for treating solid cancer…